scispace - formally typeset
Search or ask a question

Showing papers on "Polyamine binding published in 1993"


Journal ArticleDOI
TL;DR: Electrophysiological characterization of six splice variants of the NR1 receptor expressed in Xenopus oocytes identifies the contributions of the separate polypeptide domains to modulation by polyamines and PKC and provides further support for the concept that subunit composition determines functional properties of NMDA receptors.
Abstract: The N-methyl-D-aspartate (NMDA) receptor NR1 gene encodes RNA that is alternatively spliced to generate at least seven variants. The variants arise from splicing in or out of three exons; one encodes a 21-amino acid insert in the N-terminal domain, and two encode adjacent sequences of 37 and 38 amino acids in the C-terminal domain. Splicing out of the second C-terminal exon deletes a stop codon and results in an additional open reading frame encoding an unrelated sequence of 22 amino acids before arriving at a second stop codon. We denote the NR1 variants by the presence or absence of the three alternatively spliced exons (from 5' to 3'); thus, NR1(111) has all three exons, NR1(000) has none, and NR1(100) has only the N-terminal exon. We report here electrophysiological characterization of six splice variants of the NR1 receptor expressed in Xenopus oocytes. NR1 receptors that lacked the N-terminal exon (NR1(000), NR1(010), and NR1(011)) exhibited a relatively high affinity for NMDA (EC50 approximately 13 microM) and marked potentiation by spermine. In contrast, those receptor variants with the N-terminal insert (NR1(100), NR1(101), and NR1(111)) showed a lower agonist affinity and little or no spermine potentiation at saturating glycine. All six variants showed spermine potentiation at low glycine and inhibition by spermine at more negative potentials. Variants differing only in the C-terminal domain differed little in agonist affinity and spermine potentiation. These findings indicate that the N-terminal insert either participates in agonist and polyamine binding domains or indirectly modifies their conformations. The splice variants differed in the extent to which they could be potentiated by activators of protein kinase C (PKC) from 3- to 20-fold. Presence of the N-terminal insert and absence of the C-terminal sequences increased potentiation by PKC. These findings identify the contributions of the separate polypeptide domains to modulation by polyamines and PKC and provide further support for the concept that subunit composition determines functional properties of NMDA receptors.

317 citations


Journal ArticleDOI
TL;DR: It is shown that the expression of all four proteins was necessary for maximal putrescine transport activity and can also be defined as a bacterial periplasmic transport system.

110 citations


Journal ArticleDOI
TL;DR: Endogenous polyamine binding proteins were more abundant in actively dividing regions of apicalinternodes, young leaves and ovaries than in mature basal internodes, fully expanded leaves and Ovaries at the green fruit stage, respectively.
Abstract: We have previously reported the binding of exogenous labeled spermidine to a developmentally regulated 18 kD protein in thin-layer tobacco tissue cultures [1] and to protein larger than 45 kD in mesophyll protoplasts of oat [16]. To assess the possible biological importance of this phenomenon we have now studied the binding of endogenous polyamines to proteins in three developmental systems, the internodes, leaves and ovaries of tobacco (Nicotiana tabacum L cv. Wisconsin-38), each containing regions of cell division, cell enlargement and quiescence. Endogenous polyamine binding proteins were more abundant in actively dividing regions of apical internodes, young leaves and ovaries than in mature basal internodes, fully expanded leaves and ovaries at the green fruit stage, respectively. Spermidine binding was highest in young ovaries while putrescine binding was highest in young leaves. The results suggest a relation between polyamine binding proteins and mitotic activity.

46 citations


Journal ArticleDOI
TL;DR: The data indicate that β‐amyloid or substance P does not stimulate [3H] MK‐801 binding at either the N‐methyl‐D‐aspartate, glycine, or polyamine binding sites, and may have implications in the pattern of selective neuronal loss observed in patients with neurodegenerative processes such as Alzheimer's, Parkinson's, and Huntington's diseases.
Abstract: Micromolar concentrations of beta-amyloid (25-35) or substance P stimulated [3H]MK-801 binding in the presence of low concentrations of glutamate (1 microM) and glycine (0.02 microM). Unlike polyamines spermine and spermidine, neither beta-amyloid (25-35) nor substance P increased [3H]MK-801 binding in the presence of maximally stimulating concentrations of glutamate and glycine. 5,7-Dichloro-kynurenic acid, CGS-19755, and arcaine completely inhibited the stimulated [3H]MK-801 binding. There was an apparent decreased potency of the [3H]MK-801 binding inhibition curve for 5,7-dichlorokynurenic acid, but not CGS-19755 or arcaine, in the presence of either beta-amyloid (25-35) or substance P. The compounds do not appear to act through the strychnine-insensitive glycine binding site because neither beta-amyloid (25-35) nor substance P displaced [3H]glycine binding. Full-length beta-amyloid (1-40), up to 10 microM, did not stimulate [3H]MK-801 binding. Concentrations > 10 microM could not be tested because they formed large aggregate precipitates in the assay. The data indicate that beta-amyloid (25-35) or substance P does not stimulate [3H]MK-801 binding at either the N-methyl-D-aspartate, glycine, or polyamine binding sites. Furthermore, the nonpeptide substance P receptor (NK1) antagonist, CP-96,345, did not block beta-amyloid (25-35)- or substance P-stimulated [3H]MK-801 binding. Therefore, the effect is not due to an interaction between the substance P receptors and the N-methyl-D-aspartate receptor-operated ionophore. Finally, if these observations can be verified using single-channel recording techniques, they may have implications in the pattern of selective neuronal loss observed in patients with neurodegenerative processes such as Alzheimer's, Parkinson's, and Huntington's diseases.

13 citations